Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

U.S. Judge Orders Watson Executive to Comply With FTC Subpoena

A Watson Pharmaceuticals Inc. executive has been ordered by a federal judge to comply with a U.S. Federal Trade Commission subpoena in a patent case involving Cephalon Inc.’s sleep-disorder drug Provigil.

Paul Bisaro, president and chief executive officer of Corona, California-based Watson, a generic-drug maker, “has failed to demonstrate” that the subpoena “would be burdensome at all, let alone unduly so,” U.S. District Judge Colleen Kollar-Kotelly wrote in her opinion.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.